Certified by Founder Lodge
Sudo Biosciences
United States - Menlo Park, California
START UP
1 Disclosed Funding Rounds $116,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Our lead programs target the tyrosine kinase
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 21 ,2023 | Series B | $116,000,000 | |
| February, 14 ,2024 | Series B | $30,000,000 |
TPG
Enavate Sciences
Monograph Capital
Eventide Asset Management
Surveyor Capital
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
